Search research articles
Contact Us
Filters
Showing results (321-330 of 355) with videos related to
Page
of 36
Sort By:
British Journal of Haematology
|
May 18, 2006
Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma
Kevin W Song, Michael J Barnett, Randy D Gascoyne, et al.
Bone Marrow Transplantation
|
August 6, 2008
Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML
T J Nevill, D E Hogge, C L Toze, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 14, 2018
Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis
Wasithep Limvorapitak, Michael J Barnett, Donna E Hogge, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 27, 2009
IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation
Thomas J Nevill, John D Shepherd, Heather J Sutherland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 13, 2006
Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes
K W Song, M J Barnett, R D Gascoyne, et al.
Leukemia Research
|
September 3, 2008
Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels
Donna L Forrest, Shannon Trainor, Ryan R Brinkman, et al.
Nature Ecology & Evolution
|
September 16, 2022
Coral conservation in a warming world must harness evolutionary adaptation
Madhavi A Colton, Lisa C McManus, Daniel E Schindler, et al.
Blood
|
August 30, 2008
Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy
Carolyn J Owen, Cynthia L Toze, Anna Koochin, et al.
Blood
|
April 10, 2020
The miR-185/PAK6 axis predicts therapy response and regulates survival of drug-resistant leukemic stem cells in CML
Hanyang Lin, Katharina Rothe, Min Chen, et al.
Stem Cell Reviews and Reports
|
June 5, 2025
Outcomes Following Second Allogeneic Stem Cell Transplant for Graft Failure or Poor Graft Function: A Single Centre Experience
Jowon L Kim, Moss A Bruton Joe, Shanee Chung, et al.
Page
of 36
Search research articles
Search
Showing results (321-330 of 355) with videos related to
Sort By:
Page
of 36
British Journal of Haematology
|
May 18, 2006
Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma
Kevin W Song, Michael J Barnett, Randy D Gascoyne, et al.
Bone Marrow Transplantation
|
August 6, 2008
Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML
T J Nevill, D E Hogge, C L Toze, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 14, 2018
Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis
Wasithep Limvorapitak, Michael J Barnett, Donna E Hogge, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 27, 2009
IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation
Thomas J Nevill, John D Shepherd, Heather J Sutherland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 13, 2006
Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes
K W Song, M J Barnett, R D Gascoyne, et al.
Leukemia Research
|
September 3, 2008
Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels
Donna L Forrest, Shannon Trainor, Ryan R Brinkman, et al.
Nature Ecology & Evolution
|
September 16, 2022
Coral conservation in a warming world must harness evolutionary adaptation
Madhavi A Colton, Lisa C McManus, Daniel E Schindler, et al.
Blood
|
August 30, 2008
Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy
Carolyn J Owen, Cynthia L Toze, Anna Koochin, et al.
Blood
|
April 10, 2020
The miR-185/PAK6 axis predicts therapy response and regulates survival of drug-resistant leukemic stem cells in CML
Hanyang Lin, Katharina Rothe, Min Chen, et al.
Stem Cell Reviews and Reports
|
June 5, 2025
Outcomes Following Second Allogeneic Stem Cell Transplant for Graft Failure or Poor Graft Function: A Single Centre Experience
Jowon L Kim, Moss A Bruton Joe, Shanee Chung, et al.
Page
of 36